Schmidt F, Allen M, Ladebeck R, Breuer J, Judenhofer M, Schmand M
Med Phys. 2023; 51(2):991-1006.
PMID: 38150577
PMC: 10923015.
DOI: 10.1002/mp.16923.
Usanase N, Uzun B, Ozsahin D, Ozsahin I
Jpn J Radiol. 2023; 42(2):145-157.
PMID: 37733205
DOI: 10.1007/s11604-023-01486-z.
Schwenck J, Sonanini D, Cotton J, Rammensee H, Fougere C, Zender L
Nat Rev Cancer. 2023; 23(7):474-490.
PMID: 37258875
DOI: 10.1038/s41568-023-00576-4.
Zhang X, Jiang H, Wu S, Wang J, Zhou R, He X
Phenomics. 2023; 2(2):102-118.
PMID: 36939797
PMC: 9590515.
DOI: 10.1007/s43657-021-00042-x.
Liu Z, Cheng T, Duwel S, Jian Z, Topping G, Steiger K
Eur J Nucl Med Mol Imaging. 2021; 49(4):1157-1165.
PMID: 34651225
PMC: 8921117.
DOI: 10.1007/s00259-021-05574-y.
Hybrid total-body pet scanners-current status and future perspectives.
Nadig V, Herrmann K, Mottaghy F, Schulz V
Eur J Nucl Med Mol Imaging. 2021; 49(2):445-459.
PMID: 34647154
PMC: 8803785.
DOI: 10.1007/s00259-021-05536-4.
Hybrid PET-MRI for early detection of dopaminergic dysfunction and microstructural degradation involved in Parkinson's disease.
Shang S, Li D, Tian Y, Li R, Zhao H, Zheng L
Commun Biol. 2021; 4(1):1162.
PMID: 34621005
PMC: 8497575.
DOI: 10.1038/s42003-021-02705-x.
Co-registration of optoacoustic tomography and magnetic resonance imaging data from murine tumour models.
Gehrung M, Tomaszewski M, McIntyre D, Disselhorst J, Bohndiek S
Photoacoustics. 2020; 18:100147.
PMID: 32042588
PMC: 6997898.
DOI: 10.1016/j.pacs.2019.100147.
PET Scan: Nuclear Medicine Imaging in Myositis.
Selva-OCallaghan A, Gil-Vila A, Simo-Perdigo M, Trallero-Araguas E, Alvarado-Cardenas M, Pinal-Fernandez I
Curr Rheumatol Rep. 2019; 21(11):64.
PMID: 31754890
PMC: 11611048.
DOI: 10.1007/s11926-019-0864-3.
F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma.
Laudicella R, Davidzon G, Vasanawala S, Baldari S, Iagaru A
Nucl Med Mol Imaging. 2019; 53(4):296-299.
PMID: 31456863
PMC: 6694445.
DOI: 10.1007/s13139-019-00597-8.
MRI-Driven PET Image Optimization for Neurological Applications.
Zhu Y, Zhu X
Front Neurosci. 2019; 13:782.
PMID: 31417346
PMC: 6684790.
DOI: 10.3389/fnins.2019.00782.
Design, Implementation, and Evaluation of a Head and Neck MRI RF Array Integrated with a 511 keV Transmission Source for Attenuation Correction in PET/MR.
Navarro de Lara L, Frass-Kriegl R, Renner A, Sieg J, Pichler M, Bogner T
Sensors (Basel). 2019; 19(15).
PMID: 31357545
PMC: 6696210.
DOI: 10.3390/s19153297.
Seeing Better and Going Deeper in Cancer Nanotheranostics.
Sivasubramanian M, Chuang Y, Chen N, Lo L
Int J Mol Sci. 2019; 20(14).
PMID: 31315232
PMC: 6678689.
DOI: 10.3390/ijms20143490.
Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.
Stieb S, Eleftheriou A, Warnock G, Guckenberger M, Riesterer O
Eur J Nucl Med Mol Imaging. 2018; 45(12):2201-2217.
PMID: 30128659
DOI: 10.1007/s00259-018-4116-y.
The Potential of In Vivo Imaging for Optimization of Molecular and Cellular Anti-cancer Immunotherapies.
Fruhwirth G, Kneilling M, de Vries I, Weigelin B, Srinivas M, Aarntzen E
Mol Imaging Biol. 2018; 20(5):696-704.
PMID: 30030697
PMC: 6153672.
DOI: 10.1007/s11307-018-1254-3.
MR Performance in the Presence of a Radio Frequency-Penetrable Positron Emission Tomography (PET) Insert for Simultaneous PET/MRI.
Lee B, Grant A, Chang C, Watkins R, Glover G, Levin C
IEEE Trans Med Imaging. 2018; 37(9):2060-2069.
PMID: 29993864
PMC: 6195123.
DOI: 10.1109/TMI.2018.2815620.
Radiolabeled Dendrimers for Nuclear Medicine Applications.
Zhao L, Zhu M, Li Y, Xing Y, Zhao J
Molecules. 2017; 22(9).
PMID: 28841180
PMC: 6151832.
DOI: 10.3390/molecules22091350.
Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET.
van der Vos C, Koopman D, Rijnsdorp S, Arends A, Boellaard R, van Dalen J
Eur J Nucl Med Mol Imaging. 2017; 44(Suppl 1):4-16.
PMID: 28687866
PMC: 5541089.
DOI: 10.1007/s00259-017-3727-z.
Low eddy current RF shielding enclosure designs for 3T MR applications.
Lee B, Watkins R, Chang C, Levin C
Magn Reson Med. 2017; 79(3):1745-1752.
PMID: 28585334
PMC: 5718985.
DOI: 10.1002/mrm.26766.
Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response.
Timm K, Kennedy B, Brindle K
Clin Cancer Res. 2016; 22(21):5196-5203.
PMID: 27609841
PMC: 5321522.
DOI: 10.1158/1078-0432.CCR-16-0159.